Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
Year: 2019
Type: review
Abstract: In cancer, infection and inflammation, the immune system's function can be dysregulated. Instead of fighting disease, immune cells may increase pathology and suppress host-protective immune responses. Myeloid cells show high plasticity and adapt to changing conditions and pathological challenges. Despite their relevance in disease pathophysiology, the identity, heterogeneity and biology of myeloid cells is still poorly understood. We will focus on phenotypical and functional markers of one of the key myeloid regulatory subtypes, the myeloid derived suppressor cells (MDSC), in humans, mice and non-human primates. Technical issues regarding the isolation of the cells from tissues and blood, timing and sample handling of MDSC will be detailed. Localization of MDSC in a tissue context is of crucial importance and immunohistochemistry approaches for this purpose are discussed. A minimal antibody panel for MDSC research is provided as part of the Mye-EUNITER COST action. Strategies for the identification of additional markers applying state of the art technologies such as mass cytometry will be highlighted. Such marker sets can be used to study MDSC phenotypes across tissues, diseases as well as species and will be crucial to accelerate MDSC research in health and disease.
Source: Cancer Immunology Immunotherapy
Institutions: MRC Centre for Reproductive Health, The Queen's Medical Research Institute, University of Edinburgh, Oslo University Hospital, University of Oslo, Essen University Hospital, University of Duisburg-Essen, University of Verona, Friedrich-Loeffler-Institut, Universität Greifswald, Max Planck Institute for Infection Biology, Medical University of South Carolina, MUSC Hollings Cancer Center, Karolinska Institutet, Inserm, Centre Hospitalier Universitaire de Rennes, Microenvironment and B-cells: Immunopathology, Cell, Differentiation and Cancer, Université Rennes 1, Université de Rennes, German Cancer Research Center, Heidelberg University, University Medical Centre Mannheim, Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,760
OpenAlex ID: W2913153613
